動物用抗生物質および抗菌剤の世界市場予測2021:テトラサイクリン、ペニシリン、スルホンアミド、マクロライド、セファロスポリン、フルオロキノロン...市場調査レポートについてご紹介

【英文タイトル】Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Fluoroquinolone), Mode of Delivery (Premixes, Oral Powder, Injection), Animal (Food-producing & Companion) - Global Forecast to 2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Introduction (Page No. – 18)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 21)
2.1 Research Approach
2.1.1 Secondary Sources
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 29)

4 Premium Insights (Page No. – 34)
4.1 Global Animal Antimicrobials and Antibiotics Market Overview
4.2 Asia-Pacific: Animal Antimicrobials and Antibiotics Market, 2015
4.3 Animal Antimicrobials and Antibiotics Market: Geographic Growth Opportunities
4.4 Animal Antimicrobials and Antibiotics Market: Geographic Mix
4.5 Animal Antimicrobials and Antibiotics Market: Developing vs Developed Countries/Regions

5 Market Overview (Page No. – 38)
5.1 Introduction
5.2 Market Dynamics
5.3 Key Market Drivers
5.3.1 Rising Demand for Animal-Derived Food Products
5.3.2 Increasing Incidence of Zoonotic Diseases
5.3.3 Implementation of Regulations for Preventing the Spread of Animal Diseases
5.3.4 Rising Demand for Pet Insurance and Growing Animal Health Expenditure
5.4 Key Market Restraints
5.4.1 Dearth of New Antibiotics
5.4.2 Growing Resistance to Antimicrobials and Antibiotics
5.4.3 Routine Prophylactic Use of Antibiotics Being Replaced By Good Husbandry and Hygiene Practices
5.5 Key Market Opportunities
5.5.1 Untapped Emerging Markets
5.5.2 Growth in Companion Animal Population
5.6 Key Challenges
5.6.1 Stringent Approval Process for Antimicrobials and Antibiotics

6 Industry Insights (Page No. – 48)
6.1 Introduction
6.2 Industry Trends
6.2.1 Growing Consolidation in the Animal Health Industry
6.2.2 Growing Focus on Limiting the Use of Antibiotics in Livestock Animals
6.2.3 High Growth in Emerging Markets
6.3 Regulatory Analysis

7 Animal Antimicrobials and Antibiotics Market, By Product (Page No. – 55)
7.1 Introduction
7.2 Tetracyclines
7.3 Penicillins
7.4 Sulfonamides
7.5 Macrolides
7.6 Aminoglycosides
7.7 Lincosamides
7.8 Fluoroquinolones
7.9 Cephalosporins
7.1 Other Antimicrobials and Antibiotics

8 Animal Antimicrobials and Antibiotics Market, By Mode of Delivery (Page No. – 68)
8.1 Introduction
8.2 Premixes
8.3 Oral Powders
8.4 Oral Solutions
8.5 Injections
8.6 Other Modes of Delivery

9 Animal Antimicrobials and Antibiotics Market, By Type of Animal (Page No. – 75)
9.1 Introduction
9.2 Food-Producing Animals
9.2.1 Cattle
9.2.2 Pigs
9.2.3 Poultry
9.2.4 Sheep and Goats
9.2.5 Other Food-Producing Animals
9.3 Companion Animals
9.3.1 Dogs
9.3.2 Cats
9.3.3 Horses
9.3.4 Other Companion Animals

10 Animal Antimicrobials and Antibiotics Market, By Region (Page No. – 91)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Spain
10.3.2 Italy
10.3.3 Germany
10.3.4 U. K.
10.3.5 France
10.3.6 Rest of Europe
10.4 Asia-Pacific (APAC)
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia-Pacific (Rest of APAC)
10.5 Rest of the World (RoW)
10.5.1 Latin America
10.5.2 Middle East and Africa

11 Competitive Landscape (Page No. – 163)
11.1 Introduction
11.2 Market Share Analysis
11.3 Competitive Situations and Trends
11.3.1 Acquisitions
11.3.2 Product Launches
11.3.3 Agreements
11.3.4 Expansions
11.3.5 Product Acquisitions

12 Company Profiles (Page No. – 171)
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 Introduction
12.2 Zoetis, Inc.
12.3 Boehringer Ingelheim GmbH
12.4 Eli Lilly and Company
12.5 Merck & Co., Inc.
12.6 Bayer AG
12.7 Sanofi
12.8 Ceva Sante Animale
12.9 Virbac
12.10 Vetoquinol S.A.
12.11 Dechra Pharmaceuticals PLC

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 195)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.5 Introducing RT: Real-Time Market Intelligence
13.6 Available Customizations
13.7 Related Reports
13.8 Author Details


【レポート販売概要】

■ タイトル:動物用抗生物質および抗菌剤の世界市場予測2021:テトラサイクリン、ペニシリン、スルホンアミド、マクロライド、セファロスポリン、フルオロキノロン
■ 英文:Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Fluoroquinolone), Mode of Delivery (Premixes, Oral Powder, Injection), Animal (Food-producing & Companion) - Global Forecast to 2021
■ 発行日:2016年12月12日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-PH-2458
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。